LPL Financial’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $144M | Buy |
289,111
+21,049
| +8% | +$9.33M | 0.03% | 503 |
|
|
2026
Q1 | $120M | Sell |
268,062
-8,816
| -3% | -$4.11M | 0.03% | 512 |
|
|
2025
Q4 | $126M | Buy |
276,878
+12,696
| +5% | +$5.47M | 0.03% | 468 |
|
|
2025
Q3 | $103M | Buy |
264,182
+23,566
| +10% | +$9.85M | 0.03% | 507 |
|
|
2025
Q2 | $107M | Buy |
240,616
+23,672
| +11% | +$10.9M | 0.04% | 458 |
|
|
2025
Q1 | $105M | Buy |
216,944
+25,891
| +14% | +$12.1M | 0.04% | 408 |
|
|
2024
Q4 | $76.9M | Buy |
191,053
+1,340
| +0.7% | +$621K | 0.03% | 480 |
|
|
2024
Q3 | $88.2M | Sell |
189,713
-20,126
| -10% | -$9.67M | 0.04% | 418 |
|
|
2024
Q2 | $98.4M | Buy |
209,839
+26,468
| +14% | +$11.5M | 0.05% | 340 |
|
|
2024
Q1 | $76.7M | Buy |
183,371
+19,735
| +12% | +$8.34M | 0.04% | 405 |
|
|
2023
Q4 | $66.6M | Sell |
163,636
-10,101
| -6% | -$3.73M | 0.04% | 412 |
|
|
2023
Q3 | $60.4M | Buy |
173,737
+1,709
| +1% | +$598K | 0.04% | 401 |
|
|
2023
Q2 | $60.5M | Buy |
172,028
+4,528
| +3% | +$1.53M | 0.04% | 386 |
|
|
2023
Q1 | $52.8M | Buy |
167,500
+2,161
| +1% | +$648K | 0.04% | 398 |
|
|
2022
Q4 | $47.7M | Buy |
165,339
+32,264
| +24% | +$9.83M | 0.04% | 406 |
|
|
2022
Q3 | $38.5M | Sell |
133,075
-2,741
| -2% | -$789K | 0.04% | 418 |
|
|
2022
Q2 | $38.3M | Sell |
135,816
-688
| -0.5% | -$184K | 0.04% | 411 |
|
|
2022
Q1 | $35.6M | Buy |
136,504
+16,002
| +13% | +$3.8M | 0.03% | 449 |
|
|
2021
Q4 | $26.5M | Buy |
120,502
+7,919
| +7% | +$1.54M | 0.02% | 571 |
|
|
2021
Q3 | $20.4M | Buy |
112,583
+39,081
| +53% | +$7.63M | 0.02% | 620 |
|
|
2021
Q2 | $14.8M | Buy |
73,502
+10,071
| +16% | +$2.11M | 0.02% | 717 |
|
|
2021
Q1 | $13.6M | Buy |
63,431
+20,735
| +49% | +$4.55M | 0.02% | 688 |
|
|
2020
Q4 | $10.1M | Sell |
42,696
-2,219
| -5% | -$509K | 0.01% | 737 |
|
|
2020
Q3 | $12.2M | Buy |
44,915
+823
| +2% | +$227K | 0.02% | 563 |
|
|
2020
Q2 | $12.8M | Buy |
44,092
+3,864
| +10% | +$1.05M | 0.02% | 505 |
|
|
2020
Q1 | $9.57M | Buy |
40,228
+2,839
| +8% | +$651K | 0.02% | 511 |
|
|
2019
Q4 | $8.19M | Buy |
37,389
+1,068
| +3% | +$216K | 0.01% | 650 |
|
|
2019
Q3 | $6.15M | Sell |
36,321
-3,953
| -10% | -$699K | 0.01% | 713 |
|
|
2019
Q2 | $7.38M | Sell |
40,274
-2,810
| -7% | -$491K | 0.02% | 625 |
|
|
2019
Q1 | $7.92M | Sell |
43,084
-397
| -0.9% | -$73.3K | 0.02% | 583 |
|
|
2018
Q4 | $7.21M | Sell |
43,481
-765
| -2% | -$133K | 0.02% | 561 |
|
|
2018
Q3 | $8.53M | Buy |
44,246
+3,126
| +8% | +$557K | 0.02% | 546 |
|
|
2018
Q2 | $6.99M | Buy |
41,120
+2,040
| +5% | +$316K | 0.02% | 586 |
|
|
2018
Q1 | $6.37M | Sell |
39,080
-3,946
| -9% | -$645K | 0.02% | 598 |
|
|
2017
Q4 | $6.45M | Buy |
43,026
+5,887
| +16% | +$872K | 0.02% | 562 |
|
|
2017
Q3 | $5.65M | Buy |
37,139
+23,396
| +170% | +$3.52M | 0.02% | 560 |
|
|
2017
Q2 | $1.77M | Buy |
13,743
+3,641
| +36% | +$438K | 0.01% | 1013 |
|
|
2017
Q1 | $1.08M | Sell |
10,102
-3,320
| -25% | -$292K | 0.01% | 1205 |
|
|
2016
Q4 | $1M | Sell |
13,422
-3,470
| -21% | -$282K | 0.01% | 1217 |
|
|
2016
Q3 | $1.46M | Sell |
16,892
-712
| -4% | -$67.3K | 0.01% | 938 |
|
|
2016
Q2 | $1.58M | Buy |
17,604
+9,156
| +108% | +$791K | 0.01% | 889 |
|
|
2016
Q1 | $711K | Buy |
8,448
+468
| +6% | +$42.3K | ﹤0.01% | 1926 |
|
|
2015
Q4 | $985K | Sell |
7,980
-5,338
| -40% | -$644K | ﹤0.01% | 1688 |
|
|
2015
Q3 | $1.52M | Buy |
13,318
+1,125
| +9% | +$145K | 0.01% | 975 |
|
|
2015
Q2 | $1.57M | Buy |
12,193
+734
| +6% | +$92.5K | 0.01% | 1058 |
|
|
2015
Q1 | $1.33M | Buy |
11,459
+3,656
| +47% | +$438K | 0.01% | 1154 |
|
|
2014
Q4 | $927K | Buy |
7,803
+935
| +14% | +$105K | 0.01% | 1358 |
|
|
2014
Q3 | $737K | Buy |
6,868
+3,254
| +90% | +$310K | ﹤0.01% | 1499 |
|
|
2014
Q2 | $342K | Buy |
3,614
+474
| +15% | +$33.2K | ﹤0.01% | 2100 |
|
|
2014
Q1 | $222K | Buy |
3,140
+448
| +17% | +$35.5K | ﹤0.01% | 2361 |
|
|
2013
Q4 | $200K | Sell |
2,692
-10,681
| -80% | -$744K | ﹤0.01% | 2436 |
|
|
2013
Q3 | $986K | Sell |
13,373
-9,971
| -43% | -$793K | 0.01% | 1192 |
|
|
2013
Q2 | $1.87M | Buy |
+23,344
| New | +$1.72M | 0.01% | 759 |
|
Other funds holding VRTX
LPL Financial's VRTX Position: Q2 2026 in Review
LPL Financial increased its Vertex Pharmaceuticals (VRTX) stake by 7.9% in Q2 2026, buying an estimated $9.33M and bringing the position to 289,111 shares worth $144M. The position accounts for 0.03% of the portfolio, ranked #503.
LPL Financial first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- LPL Financial held 289,111 shares of Vertex Pharmaceuticals worth $144M as of Q2 2026.
- LPL Financial bought 21,049 Vertex Pharmaceuticals shares in Q2 2026, an estimated $9.33M.
- Vertex Pharmaceuticals made up 0.03% of LPL Financial's portfolio in Q2 2026, its #503 holding.
- LPL Financial first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.